The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial.
Urol. Oncol., Dec (2011)
Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.
J. Clin. Oncol., Jun;28(16):2668-73 (2010)
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
Cancer., May;112(10):2181-7 (2008)
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.
Clin Genitourin Cancer., Dec;5(3):219-26 (2006)
Actual use and perceived usefulness of a web-based, decision support program for men with prostate cancer.
Stud Health Technol Inform., 122:781-2 (2006)
Evidence for the expression of radiation-induced potentially lethal damage being a p53-dependent process.
Int. J. Radiat. Biol., Aug;76(8):1037-43 (2000)
The effect of functional inactivation of TP53 by HPV-E6 transformation on the induction of chromosome aberrations by gamma rays in human tumor cells.
Radiat. Res., Apr;151(4):385-90 (1999)
Fast neutrons in prostatic adenocarcinomas: worldwide clinical experience.
Recent Results Cancer Res., 150:125-36 (1998)
Neutron beam radiotherapy for recurrent prostate cancer following radical prostatectomy.
Int. J. Radiat. Oncol. Biol. Phys., Apr;41(1):93-9 (1998)
Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.
Int. J. Radiat. Oncol. Biol. Phys., Dec;36(5):1099-106 (1996)
Clinical trials of neutron radiotherapy in the United States.
Bull Cancer Radiother., 83 Suppl:78s-86s (1996)
Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
Cancer Res., Apr;55(8):1639-42 (1995)
Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats.
Int. J. Radiat. Oncol. Biol. Phys., Jan;31(1):71-7 (1995)
Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial.
Int. J. Radiat. Oncol. Biol. Phys., Jan;28(1):47-54 (1994)
Fast neutron radiation therapy. Results of phase III randomized trials in head and neck, lung, and prostate cancers.
Acta Oncol., 33(3):293-8 (1994)
Fast neutron radiotherapy. The University of Washington experience.
Acta Oncol., 33(3):275-80 (1994)
Femoral vessel depth and the implications for groin node radiation.
Int. J. Radiat. Oncol. Biol. Phys., Nov;27(4):969-74 (1993)
Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer.
Int. J. Radiat. Oncol. Biol. Phys., Aug;26(5):809-16 (1993)
Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial.
Am. J. Clin. Oncol., Apr;16(2):164-7 (1993)
Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy.
J. Urol., Oct;146(4):1046-52 (1991)
Intraoperative electron beam therapy.
Radiol Med., Oct;80(4 Suppl 1):86-7 (1990)
Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder.
Int. J. Radiat. Oncol. Biol. Phys., Sep;19(3):693-9 (1990)
Transient and chronic neurological complications of fast neutron radiation for adenocarcinoma of the prostate.
Radiother Oncol., Jul;18(3):257-65 (1990)
Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies.
Int. J. Radiat. Oncol. Biol. Phys., Mar;18(3):523-8 (1990)
Fast neutron radiotherapy for sarcomas of soft tissue, bone, and cartilage.
Am. J. Clin. Oncol., Aug;12(4):320-6 (1989)
Fast neutron radiotherapy for the treatment of carcinoma of the urinary bladder. A review of clinical trials.
Am. J. Clin. Oncol., Aug;12(4):301-6 (1989)
Neutron radiation therapy for unresectable non-small-cell carcinoma of the lung. A review.
Am. J. Clin. Oncol., Aug;12(4):290-4 (1989)
Fast neutron radiotherapy in the treatment of locally advanced adenocarcinoma of the prostate. Clinical experience and future directions.
Am. J. Clin. Oncol., Aug;12(4):307-10 (1989)
Fast neutron radiotherapy for locally advanced prostate cancer. Update of a past trial and future research directions.
Urology., Jul;34(1):1-9 (1989)
Response of mediastinal Hodgkin's disease to radiotherapy: rate of tumor regression not predictive of outcome.
Int. J. Radiat. Oncol. Biol. Phys., Jan;16(1):201-4 (1989)
Improved radiotherapy treatment planning for spinal cord tumors using gadolinium enhanced MR imaging.
Med Dosim., 14(1):5-8 (1989)
Combined intracavitary and external beam irradiation for superficial transitional cell carcinoma of the bladder: an alternative to cystectomy for patients with recurrence after intravesical chemotherapy.
J. Urol., Jan;141(1):30-2 (1989)
Invasive bladder cancer. Strategies for cure and bladder preservation.
Hematol. Oncol. Clin. North Am., Sep;2(3):447-55 (1988)
Fast neutron irradiation of locally advanced prostate cancer.
Semin. Oncol., Aug;15(4):359-65 (1988)
Prophylactic cranial irradiation for limited non-small cell lung cancer.
Cancer., Jul;62(1):36-9 (1988)
Fast neutron radiotherapy for advanced malignant salivary gland tumors.
Radiother Oncol., Jun;12(2):105-11 (1988)
Transitional cell carcinoma of the urinary bladder: histologic clearance with combined 5-FU chemotherapy and radiation therapy. Preliminary results of a bladder-preservation study.
Radiology., Jun;167(3):845-8 (1988)
Adjunctive hysterectomy following radiation therapy for bulky carcinoma of the uterine cervix: prognostic implications of tumor persistence.
Gynecol. Oncol., Oct;28(2):220-4 (1987)
Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract.
Gynecol. Oncol., Jun;27(2):226-32 (1987)
High dose para-aortic lymph node irradiation for gynecologic cancer: technique, toxicity, and results.
Int. J. Radiat. Oncol. Biol. Phys., Feb;13(2):267-71 (1987)
Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: updated results of the RTOG 7704 randomized clinical trial.
Prostate., 11(2):183-93 (1987)
In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
Cancer Res., Jun;46(6):2883-7 (1986)
Childhood Hodgkin's disease: patterns of relapse.
J. Clin. Oncol., Feb;2(2):80-7 (1984)